The Pharmaceutical Research and Manufacturers of America (PhRMA) has hired Geoffrey Becker to join its State Government Affairs team, adding a seasoned government affairs leader with more than two decades of experience shaping health care policy at the state and national levels.
PhRMA represents the country’s leading biopharmaceutical research companies and advocates for public policies that support scientific innovation, patient access to medicines, and a strong U.S. life sciences ecosystem.
At the state level, PhRMA works with policymakers, patients, physicians and other stakeholders to advance policies that encourage the discovery of new medicines, promote market-based access and avoid unintended consequences that can limit patient care or future innovation.
Becker brings more than two decades of experience in health care policy and government affairs to the role. Most recently, he served as Government Affairs Program Director at Medtronic, where he led state advocacy efforts focused on patient access, innovation, and regulatory policy, including navigating complex reimbursement and coverage environments.
“I have known and worked with Geoffrey for more than a decade and have always respected his work in each role he’s served,” said Sen. Ed Hooper, a Clearwater Republican and Chair of the Senate Appropriations Committee. “He understands Florida’s policy landscape and how decisions made here impact patients and innovation. I look forward to continuing to work with him as he assumes this new leadership position.”
Becker has deep Florida experience, having previously served in senior roles in state government, including Deputy Chief of Staff in the Executive Office of Gov. Rick Scott and Assistant Secretary for Administration at the Florida Department of Children and Families.
“I’m excited to join PhRMA and continue working at the intersection of public policy, innovation, and patient access,” Becker said. “State-level decisions increasingly shape how patients access care, and I look forward to collaborating with policymakers and stakeholders to advance practical, patient-centered solutions that support innovation and improve health outcomes.”
At PhRMA, Becker will focus on advancing state-level advocacy strategies that support the value of biopharmaceutical innovation, improve patient access to medicines, and promote policies that strengthen health systems and communities nationwide.
